Psoriatic Arthritis Archives - Page 2 of 4 - MPR

Psoriatic Arthritis

Psoriasis Elbow

NDA for Plaque Psoriasis Treatment Wynzora Submitted for Review

The New Drug Application (NDA) for Wynzora Cream (calcipotriene 0.005% and betamethasone dipropionate 0.064%; MC2 Therapeutics) has been submitted to the Food and Drug Administration (FDA) for the treatment of plaque psoriasis. Wynzora combines calcipotriene, a vitamin D3 analogue, and betamethasone dipropionate, a corticosteroid, using the Company’s proprietary PAD Technology platform, which enables stability of…